⌘K

Login Start Free

Home/Filings/4/0001104659-21-070074

4//SEC Filing

Lippa Arnold 4

Accession 0001104659-21-070074

CIK 0001583771other

View on SEC.gov Company Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 7:12 PM ET

Size

5.5 KB

Accession

0001104659-21-070074

Insider Transaction Report

Form 4

Period: 2021-05-18

Hepion Pharmaceuticals, Inc.HEPA

Director

Transactions

Award
Stock Options
2021-05-18+200,000→ 291,110 total
Exercise: $1.70From: 2022-05-18Exp: 2031-05-18→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Documents

1 file

4
tm2117144-7_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1

filerCIK 0001363763

Filing Metadata

Form type: 4
Filed: May 19, 8:00 PM ET
Accepted: May 20, 7:12 PM ET
Size: 5.5 KB

View on SEC.gov